Publications by authors named "N Salvadori"

Burgers have become a staple of global cuisine and can have several different versions and combinations. For example, hybrid burgers have a percentage of animal protein in their formulation, while plant-based burgers contain 100% plant-based proteins. Therefore, the aim of this study was to investigate the emerging trends and challenges in the formulation of hybrid and plant-based burgers, with an emphasis on new ingredients and the evaluation of their physical, chemical, and sensory properties.

View Article and Find Full Text PDF

Sustainable food practices are intrinsically linked to human nutrition in the preservation of the ecosystem. This study, therefore, evaluates the effectiveness, challenges, environmental impacts, and new food strategies related to plant and animal products, with a view to promoting more sustainable and healthy eating practices. The search stages were conducted using the following databases: PubMed, Science Direct, and SciElo.

View Article and Find Full Text PDF

Background: The direct acting antiviral remdesivir (RDV) has shown promising results in randomized clinical trials. This study is a unique report of real clinical practice RDV administration for COVID-19 from alpha through delta variant circulation in New Orleans, Louisiana (NOLA). Patients in NOLA have among US worst pre-COVID health outcomes, and the region was an early epicenter for severe COVID.

View Article and Find Full Text PDF

Neuropsychological evidence of memory impairment represents the main feature of the clinical onset of typical Alzheimer's disease (AD). Rey's Auditory Verbal Learning Test (RAVLT) and Logical Memory (LM) are two tests both assessing verbal episodic memory, widely used in clinical practice. Our aim was to investigate the added value of their combined use in predicting cerebrospinal fluid (CSF) AD biomarkers positivity in a retrospective consecutive series of patients with mild cognitive impairment (MCI).

View Article and Find Full Text PDF
Article Synopsis
  • Ravidasvir (RDV) is a new drug that effectively inhibits the hepatitis C virus (HCV) replication and has shown promising results when combined with Sofosbuvir (SOF) in trials involving adults, including those co-infected with HIV.
  • In a study conducted in Thailand and Malaysia, RDV was given to both patients with and without cirrhosis for various durations, and pharmacokinetics (how the drug behaves in the body) were evaluated through blood sampling at different intervals.
  • The analysis revealed that RDV levels were influenced by several factors; however, these variations were not significant enough to impact the drug's effectiveness across the diverse group of participants, and there were no significant drug interactions for
View Article and Find Full Text PDF